Painful hypertrophic osteoarthropathy successfully treated with octreotide. The pathogenetic role of vascular endothelial growth factor (VEGF).
A
A
Angel-Moreno Maroto
E
E
Martínez-Quintana
L
L
Suárez-Castellano
J-L
JL
Pérez-Arellano
D000328:Adult; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000188:drug therapy*; D013771:Tetralogy of Fallot / Q000150:complications; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D042461:Vascular Endothelial Growth Factor A; D015282:Octreotide